Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma

19 Feb 2015

Abstract excerpt

// Fenja M Feld 1 , Philipp D Nagel 1 , Stephanie E Weissinger 1 , Claudia Welke 2 , Albrecht Stenzinger 3 , Peter Möller 1 , Jochen K Lennerz 1 1 Institute of Pathology, University Ulm 89081, Germany 2 Comprehensive Cancer Center Ulm, University Hospital Ulm 89081, Germany 3 University Hospital Heidelberg, Department of Pathology, University Heidelberg 69120, Germany Correspondence to: Jochen K. Lennerz, e-mail:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25595905
DOI: 10.18632/oncotarget.2799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinomaPMID 25595905Read ↗

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic CancerSemantic proximity Read ↗

A cancer cell-intrinsic GOT2-PPARδ axis suppresses antitumor immunitySemantic proximity Read ↗

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.Semantic proximity Read ↗

Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancerSemantic proximity Read ↗

Pan-cancer molecular signatures connecting aspartate transaminase (AST) to cancer prognosis, metabolic and immune signaturesSemantic proximity Read ↗

Aspartate Transaminases Are Dispensable for Pancreatic Development and Pancreatic Cancer ProgressionSemantic proximity Read ↗

Glutamine-restricted diets restore sensitivity to KRASG12D inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.Semantic proximity Read ↗

Metabolic phenotypes in pancreatic cancer.Semantic proximity Read ↗

Hypoxia-induced MIR31HG expression promotes partial EMT and basal-like phenotype in pancreatic ductal adenocarcinoma based on data mining and experimental analysesSemantic proximity Read ↗

Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.Semantic proximity Read ↗

Functional non-invasive detection of glycolytic pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Glucose metabolic phenotype of pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.